Graph AI develops Graph Safety, an AI-native SaaS platform built on its proprietary graphx platform to automate pharmacovigilance workflows including source intake, case processing, aggregate reporting, signal detection, and risk management. The platform is already live with enterprise customers and automates individual case safety reports, with further advanced capability enhancements planned. Founded in 2024 by industry veterans, the company has quickly progressed from a $3 million seed round led by Bessemer Venture Partners to advanced Series A discussions. Reported Series A talks center on raising about $14 million led by Insight Partners with continued support from Bessemer. The company positions its product as a unified, connected workflow addressing regulatory requirements across a drug's lifecycle from trials to post-market use.

Total raised

$17M

Funding rounds

2

Latest round

Series A

Latest activity

Jul 2026